MYOV News and Press, Myovant Sciences Ltd. From 02/03/20

Myovant Sciences ( MYOV ) was founded in 2016 and is based in Brisbane, CA, and Basel, Switzerland. The company's pipeline is focused on the diseases of women's health. The key flagship molecule is Relugolix, a direct antagonist of Gonadotropin-releasing hormone, GnRH. It is already available ...

Source: GraycellAdvisors.com Systematic Investing Systematic investing has become a growing part of the stock market. The investing style refers to a rules-based algorithmic system that limits or eliminates individual judgments and biases towards portfolio selection and adjustments. ...

The following slide deck was published by Myovant Sciences Ltd. in conjunction with this Read more ...

Myovant Sciences (NYSE: MYOV) stock trailed a booming market last year by falling 5% compared to a 29% spike in the S&P 500, according to data provided by S&P Global Market Intelligence . That small annual change doesn't describe the roller-coaster ride that shareholders endured, t...

Biotech Pulse The biotech group closed 2019 with its longest rally of the year. It was a welcome change from what had mostly been an uphill battle. While the broader market was sailing from one high to another, biotechs and pharmaceuticals (biopharma) were still marking their 2019 lows in ea...

BASEL, Switzerland, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on developing innovative treatments for women's health and prostate cancer, today announced that Lynn Seely, M.D., Myovant’s CEO, will present at the 38th Annual J.P. Mor...

We've run through 10 different sectors or styles of investing in our year-end Marketplace Roundtable series. You can review the full list of roundtables at the end of this article in case you'd like to catch up on any specific angle. As we do every year, we conclude the series with the com...

2019 finishes with an extra kick for investors. Part of that is the continued strong run of the market, erasing memories of last year's near bear market and extending the decade-long bull. There also are plenty of market headlines and events that have sprung over the end of the year, from Ph...

Myovant Sciences ( MYOV ) is a biotech that should be on everyone's radar. That's because it has been able to achieve positive results in several indications, with the most recent positive results coming out of the HERO study using relugolix to treat men with advanced prostate cancer. This l...

InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...